Alzheimer's disease (AD) is a hereditary, progressive, neurodegenerative disease characterized by impaired brain function, personality, and decreased cognitive (affective) functions. Although there is currently no consensus on the origin of the disease, it is unclear whether this is due to a genetic predisposition to the disease, atrophy, ovulation, and impaired functioning. It is possible that the cause of death could have been a heart attack. Samara did not participate in the clinical trials conducted between the two usability studies, which indicates that she was diagnosed with Alzheimer's disease. Thus, there are antiviral and alternative methods to prevent infection with the virus. Scientists from the University of Illinois have found that the phytoncides contained in them and the phytoncides contained in them have antioxidant and anti-inflammatory effects. Clinical manifestations: Alzheimer's disease, neurodegenerative diseases, medications, medications, alternative treatment methods. Judo For the treatment of Alzheimer's disease (ASF)New and alternative treatments have been developed to achieve therapeutic goals. Turmeric is used in the treatment of pulmonary tuberculosis, as well as in the treatment of acne. Curcuminoids are a mixture of curcumin, demethoxycurcumin and bisdemethoxycurcumin, which are the active ingredients of turmeric. In addition, turmeric is used as an important component of this blend. The Pharaonic doctors ar-Razi (Razes), al—Mazhusi (Abu Ali Abbas) and Ibn Sina (Avicenna) are among the so-called Mashiuri doctors who studied this kind. They knew well the herbal medicine not only of Nazarius, but also of his Amalie [1, 4]. Turmeric is one of the most popular medicines, its properties and healing properties are described in a number of monographs.

x

1. Fusar-Poli L., Vozza L., Gabbiadini A., Vanella A., Concas I, Tinacci S. et al. (2020) Curcumin in depression: meta-analysis. Crit Rev Food Sci Nutr 60(15):2643–2653 2. Saraf-Bank S., Ahmadi A., Paknahad Z., Marasi M., Nurian M. (2019)

The effect of curcumin supplementation on markers of inflammation and oxidative stress in healthy overweight and obese adolescent girls: a randomized, placebo-controlled clinical trial. Phytother Res 33(8):2015–2022.

3. Nurova Z.H. Cardioembolic stroke neuroprotection is important / / Yangi kun medicine. Bukhara, 2021. – № 2 (34/3). – B. 262-264 (14.00.00. № 22).

4. Khodjieva D.T., Nurova Z.H. Optimization of diagnosis and treatment of early neurological complications in cardioembolic stroke // American journal of medicine and medical sciences– 2021, – Vol 11. – P. 137-139.

5. Nurova Z.H. Cardioembolic stroke erta neurologist asoratlarini davolas // Journal of Neurology and Neurosurgical Research. Tashkent, 2021. – No. 3. – B. 250-251.

6. D. Khodzhieva.T., Nurova Z.H. Treatment of cardioembolic strokes in the acute period // Journal of Neurological and Neurosurgical Research. Tashkent, - 2022. – No. 3. – B. 71-74.

7. D. Khodzhieva.T., Nurova Z.H. Diagnosis of atrial fibrillation, cardioembolic stroke / / Yangi kun medicine. Bukhara, 2024. – № (70). – B. 309-315.

8. Nurova Z.H. Optimization of the complex of early rehabilitation of patients with cardioembolic stroke / / Science research development journal. Berlin, 2020 – P. 60-61.

Khadjiyeva D.T., Nurova Z.H. Optimization of treatment of early neurological complications in cardioembolic stroke // Salon bio and construction. Strasbourg, 2021– pp. 38-39.

Nurova Z.H. Treatment of early neurological disorders in cardioembolic stroke // Bukhara, 2021. – B. 234-235.

Nurova Z.H. D. Khodzhieva.T. Treatment of early neurological complications in cardioembolic stroke // Education and science in the XXI century. 2021. – No. (20). – P. 522-526.

Nurova Z.H. Diagnosis of a patient with a cardioembolic stroke // Journal for innovative development in pharmaceutical and technical science – 2021.P. 254-256.

Nurova Z.H. Ischemic stroke // Eurasian journal of medical and natural sciences – 2022. – Vol 2. – P. 67-72.

Nurova Z.H., D. Khodzhieva.T. Cardioembolic stroke in patients with coronary artery disease and optimal neuroprotective therapy electronic instruction: EM as instruction. DGU 10629.

Nurova Z.H. Cardioembolic stroke in patients with coronary artery disease and optimal neuroprotective therapy electronic instruction: EM as instruction. DGU 46417.

Nurova Z.H., D. T. Khodzhieva. Cardioembolic patients with stroke often suffer from stroke-related complications // Style recommendations. - Bukhara, 2024. - 23 p.

Garcia D, Libby E, Crowther MA. The new oral anticoagulants. Blood, 2010, 115: 15-20.

Kitagawa K, Toyoda K, Kitazono T, Nishikawa M, Nanto S, Ikeda Y, Abe K, Ogawa A. Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II. Cerebrovasc Dis. 2020; 49(2):152-159.